160 related articles for article (PubMed ID: 23801612)
41. Leukotriene D4 (LTD4) activates charybdotoxin-sensitive and -insensitive K+ channels in ehrlich ascites tumor cells.
Hoffmann EK
Pflugers Arch; 1999 Aug; 438(3):263-8. PubMed ID: 10398854
[TBL] [Abstract][Full Text] [Related]
42. CysLT
Sekioka T; Kadode M; Yonetomi Y; Kamiya A; Fujita M; Nabe T; Kawabata K
Eur J Pharmacol; 2017 Jan; 794():147-153. PubMed ID: 27887950
[TBL] [Abstract][Full Text] [Related]
43. Functional characterization of receptors for cysteinyl-leukotrienes in sheep trachealis muscle.
Jonsson EW
Pulm Pharmacol Ther; 1997; 10(1):29-36. PubMed ID: 9344830
[TBL] [Abstract][Full Text] [Related]
44. Leukotriene D4-induced increases in cytosolic calcium in THP-1 cells: dependence on extracellular calcium and inhibition with selective leukotriene D4 receptor antagonists.
Chan CC; Ecclestone P; Nicholson DW; Metters KM; Pon DJ; Rodger IW
J Pharmacol Exp Ther; 1994 Jun; 269(3):891-6. PubMed ID: 8014876
[TBL] [Abstract][Full Text] [Related]
45. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.
Bäck M; Kumlin M; Cotgreave IA; Dahlén SE
Br J Pharmacol; 2001 Aug; 133(7):1134-44. PubMed ID: 11487525
[TBL] [Abstract][Full Text] [Related]
46. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist.
Nothacker HP; Wang Z; Zhu Y; Reinscheid RK; Lin SH; Civelli O
Mol Pharmacol; 2000 Dec; 58(6):1601-8. PubMed ID: 11093801
[TBL] [Abstract][Full Text] [Related]
47. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
[TBL] [Abstract][Full Text] [Related]
48. Induction of granulocytic differentiation in myeloblasts by hydroquinone, a metabolite of benzene, involves the leukotriene D4 receptor.
Hazel BA; Kalf GF
Recept Signal Transduct; 1996; 6(1):1-12. PubMed ID: 8933618
[TBL] [Abstract][Full Text] [Related]
49. IL-18 accelerates the cell apoptosis by up-regulating cysteinyl leukotriene 2 receptor expression in human umbilical vein endothelial cells at the early stage of administration.
Zhou G; Zhou Z; Ge S; Liu D; Zhang R; Xu G; Zhu W; Yin Q; Chen AF; Liu X
Vascul Pharmacol; 2009; 50(5-6):171-7. PubMed ID: 19563734
[TBL] [Abstract][Full Text] [Related]
50. CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4.
Espinosa K; Bossé Y; Stankova J; Rola-Pleszczynski M
J Allergy Clin Immunol; 2003 May; 111(5):1032-40. PubMed ID: 12743568
[TBL] [Abstract][Full Text] [Related]
51. [Effects of cysteinyl receptor agonist and antagonists on rat primary cortical neurons].
Hu X; Ge QF; Zhang WP; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 36(2):117-22. PubMed ID: 17443896
[TBL] [Abstract][Full Text] [Related]
52. Characterization of the human cysteinyl leukotriene CysLT1 receptor.
Lynch KR; O'Neill GP; Liu Q; Im DS; Sawyer N; Metters KM; Coulombe N; Abramovitz M; Figueroa DJ; Zeng Z; Connolly BM; Bai C; Austin CP; Chateauneuf A; Stocco R; Greig GM; Kargman S; Hooks SB; Hosfield E; Williams DL; Ford-Hutchinson AW; Caskey CT; Evans JF
Nature; 1999 Jun; 399(6738):789-93. PubMed ID: 10391245
[TBL] [Abstract][Full Text] [Related]
53. Leukotriene D4 activates alveolar epithelial Na,K-ATPase and increases alveolar fluid clearance.
Sloniewsky DE; Ridge KM; Adir Y; Fries FP; Briva A; Sznajder JI; Sporn PH
Am J Respir Crit Care Med; 2004 Feb; 169(3):407-12. PubMed ID: 14578215
[TBL] [Abstract][Full Text] [Related]
54. Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor.
Casas A; Gómez FP; Dahlén B; Roca J; Barberà JA; Dahlén SE; Rodríguez-Roisin R
Eur Respir J; 2005 Sep; 26(3):442-8. PubMed ID: 16135725
[TBL] [Abstract][Full Text] [Related]
55. Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody.
Underwood DC; Osborn RR; Newsholme SJ; Torphy TJ; Hay DW
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):850-7. PubMed ID: 8887574
[TBL] [Abstract][Full Text] [Related]
56. Leukotriene D4 induces amyloid-β generation via CysLT(1)R-mediated NF-κB pathways in primary neurons.
Wang XY; Tang SS; Hu M; Long Y; Li YQ; Liao MX; Ji H; Hong H
Neurochem Int; 2013 Feb; 62(3):340-7. PubMed ID: 23318673
[TBL] [Abstract][Full Text] [Related]
57. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
Wunder F; Tinel H; Kast R; Geerts A; Becker EM; Kolkhof P; Hütter J; Ergüden J; Härter M
Br J Pharmacol; 2010 May; 160(2):399-409. PubMed ID: 20423349
[TBL] [Abstract][Full Text] [Related]
58. Cysteinyl leukotrienes synergize with growth factors to induce proliferation of human bronchial fibroblasts.
Yoshisue H; Kirkham-Brown J; Healy E; Holgate ST; Sampson AP; Davies DE
J Allergy Clin Immunol; 2007 Jan; 119(1):132-40. PubMed ID: 17208594
[TBL] [Abstract][Full Text] [Related]
59. Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation.
Huang XJ; Zhang WP; Li CT; Shi WZ; Fang SH; Lu YB; Chen Z; Wei EQ
Glia; 2008 Jan; 56(1):27-37. PubMed ID: 17910051
[TBL] [Abstract][Full Text] [Related]
60. Pranlukast inhibits NF-kappa B activation in human monocytes/macrophages and T cells.
Ichiyama T; Hasegawa S; Umeda M; Terai K; Matsubara T; Furukawa S
Clin Exp Allergy; 2003 Jun; 33(6):802-7. PubMed ID: 12801316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
